March 31 (Reuters) – Novo Nordisk has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off competition from cheaper ...

BENGALURU -- Ameya Nagarajan forks out nearly 25,000 rupees ($270) every month for weight-loss drugs, 20% more than the average monthly income of a salaried Indian.

A fully-featured, console-based Cab Booking System built in Java that demonstrates 15 core Object-Oriented Programming concepts through a real-world ride-hailing simulation. The system covers ...

In a significant development for diabetes and obesity care, the patent for semaglutide - the key molecule behind blockbuster drugs like Ozempic and Wegovy, expired on March 20. Originally developed by ...

Multiple domestic pharmaceutical companies launched generic semaglutide on Saturday, a day after the drug's patent expired in India, with prices falling by as much as 90% from the branded version, ...

https://www.thehindubusinessline.com/companies/generic-versions-of-novo-nordisks-semaglutide-begin-to-flow-priced-50-80-lower-than-the-innovator/article70769849.ece ...

India’s anti-obesity and diabetes drug market is heading for a sharp price reset, with generic semaglutide makers preparing to launch products at prices that could significantly undercut Novo ...

MUMBAI – A deluge of weight-loss drugs is set to transform the global fight against obesity, as India prepares to unleash low-cost generic versions of injections like Ozempic after a key patent ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

India's pharma industry is ready to flex its generics muscle as the patent for a key ingredient of blockbuster weight-loss drugs expires today. Pharmarack estimates India’s weight-loss drug market to ...

With patents expiring today in India for Novo Nordisk’s popular diabetes and obesity drugs Ozempic and Wegovy, more than 40 generic drug makers are expected to begin launching their cheaper versions ...